Table 1 Case reports of SLE during pregnancy with uterine wall thinning and PAS
Author,year | Age(y) | Parity | PSL duration(y) | PSL use during pregnancy | Risk factors of PAS | Obstetric complication | GA at labror(wk) | Induction labor | Delivery | Treatment | Amount of blood loss(ml) |
|---|---|---|---|---|---|---|---|---|---|---|---|
Noh JJ et al., 2013 [2] | 36 | 0 | 19 | Yes | IVF | Rupture uterus | 23 | None | CS | Hysterectomy | NS |
Tokushige Y et al., 2017 [3] | 35 | 0 | 5 | Yes | IVF | GH | 39 | Yes (Oxytocin) | CS | Hysterectomy | 4500 |
Tomimatsu T et al., 2021 [4] | 32 | 0 | 8 | Yes | IVF | PE | 35 | Yes (Oxytocin) | CS | Hysterectomy | 2200 |
Mittal N et al., 2018 [5] | 36 | 2 | 9 | Yes | Placenta previa | Placenta previa | 36 | None | CS | Hysterectomy | 6000 |
Kim HM et al., 2020 [6] | 33 | 0 | 10 | Yes | None | Rupture uterus | 34 | None | CS | Hysterectomy | NS |
Kim HM et al., 2020 [6] | 30 | 0 | 8 | NS | None | None | 38 | None | CS | Hysterectomy | NS |
Inoue A et al., 2020 [7] | 37 | 0 | 19 | Yes | IVF | NRFS,FGR | 36 | None | CS | Hysterectomy | 5860 |
Our case | 29 | 0 | 2 | none | none | none | 39 | Yes (Oxytocin) | CS | Hysterectomy | 5400 |